GSK’s Arexvy Is A Vaccine Approved To Protect Older Adults From Respiratory Syncytial Virus (RSV) Disease In Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for…
GSK Malaysia Launches Second Phase Of #Giveback Campaign In Conjunction With World Environment Day, Championing Responsible Disposal Of Medical Waste
GSK Malaysia is taking the lead in promoting responsible disposal of medical waste with the second…